Vaginal atrophy and genital pain in women on depot medroxyprogesterone acetate contraceptive injection.
Aust N Z J Obstet Gynaecol
; 64(2): 160-164, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-37817446
Depot medroxyprogesterone acetate causes a hypo-estrogenic state in over half of users although clinical vaginal atrophy causing superficial dyspareunia is thought rarely to occur. This is a case series of ten women using depot medroxyprogesterone acetate who presented with superficial dyspareunia and clinical vaginal atrophy. The women were treated with vaginal estriol cream and their contraception was discontinued or changed. All patients had either a complete resolution of symptoms or a substantial improvement at follow-up, and the clinical and laboratory findings of vaginal atrophy had resolved. This case series demonstrates that vaginal atrophy may occur more frequently than previously thought.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Vaginales
/
Anticonceptivos Femeninos
/
Dispareunia
Límite:
Female
/
Humans
Idioma:
En
Revista:
Aust N Z J Obstet Gynaecol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Nueva Zelanda
Pais de publicación:
Australia